United States Biopharmaceuticals Market Report 2016

Publisher Name :
Date: 30-Sep-2016
No. of pages: 123
Inquire Before Buying

Notes:

Sales, means the sales volume of Biopharmaceuticals

Revenue, means the sales value of Biopharmaceuticals

This report studies sales (consumption) of Biopharmaceuticals in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Abbott Laboratories

- Amgen

- Astrazeneca

- BASF

- Bayer

- Biocon

- Biogen Idec

- Boehringer Ingelheim

- Bristol-Myers Squibb

- Daiichi Sankyo

- Eli Lilly and Company

- Genentech

- Glaxosmithkline

- Hospira

- Johnson & Johnson

- LG Life Sciences

- Novartis

- Novo Nordisk

- Pfizer

- Ranbaxy Laboratories

- Roche Holding

- Sanofi

- Takeda Pharmaceutical Company

- Teva Pharmaceutical Industries

- UCB

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Biopharmaceuticals in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Biopharmaceuticals Market Report 2016

Table of Contents
United States Biopharmaceuticals Market Report 2016
1 Biopharmaceuticals Overview
1.1 Product Overview and Scope of Biopharmaceuticals
1.2 Classification of Biopharmaceuticals
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Biopharmaceuticals
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Biopharmaceuticals (2011-2021)
1.4.1 USA Biopharmaceuticals Sales and Growth Rate (2011-2021)
1.4.2 USA Biopharmaceuticals Revenue and Growth Rate (2011-2021)
2 USA Biopharmaceuticals Competition by Manufacturers
2.1 USA Biopharmaceuticals Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Biopharmaceuticals Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Biopharmaceuticals Average Price by Manufactures (2015 and 2016)
2.4 Biopharmaceuticals Market Competitive Situation and Trends
2.4.1 Biopharmaceuticals Market Concentration Rate
2.4.2 Biopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Biopharmaceuticals Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Biopharmaceuticals Sales and Market Share by Type (2011-2016)
3.2 USA Biopharmaceuticals Revenue and Market Share by Type (2011-2016)
3.3 USA Biopharmaceuticals Price by Type (2011-2016)
3.4 USA Biopharmaceuticals Sales Growth Rate by Type (2011-2016)
4 USA Biopharmaceuticals Sales (Volume) by Application (2011-2016)
4.1 USA Biopharmaceuticals Sales and Market Share by Application (2011-2016)
4.2 USA Biopharmaceuticals Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Biopharmaceuticals Manufacturers Profiles/Analysis
5.1 Abbott Laboratories
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Biopharmaceuticals Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Abbott Laboratories Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Amgen
5.2.2 Biopharmaceuticals Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Amgen Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Astrazeneca
5.3.2 Biopharmaceuticals Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Astrazeneca Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 BASF
5.4.2 Biopharmaceuticals Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 BASF Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Bayer
5.5.2 Biopharmaceuticals Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Bayer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Biocon
5.6.2 Biopharmaceuticals Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Biocon Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Biogen Idec
5.7.2 Biopharmaceuticals Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Biogen Idec Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Boehringer Ingelheim
5.8.2 Biopharmaceuticals Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Boehringer Ingelheim Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Bristol-Myers Squibb
5.9.2 Biopharmaceuticals Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Bristol-Myers Squibb Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Daiichi Sankyo
5.10.2 Biopharmaceuticals Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Daiichi Sankyo Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Eli Lilly and Company
5.12 Genentech
5.13 Glaxosmithkline
5.14 Hospira
5.15 Johnson & Johnson
5.16 LG Life Sciences
5.17 Novartis
5.18 Novo Nordisk
5.19 Pfizer
5.20 Ranbaxy Laboratories
5.21 Roche Holding
5.22 Sanofi
5.23 Takeda Pharmaceutical Company
5.24 Teva Pharmaceutical Industries
5.25 UCB
6 Biopharmaceuticals Manufacturing Cost Analysis
6.1 Biopharmaceuticals Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Biopharmaceuticals
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Biopharmaceuticals Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Biopharmaceuticals Market Forecast (2016-2021)
10.1 USA Biopharmaceuticals Sales, Revenue Forecast (2016-2021)
10.2 USA Biopharmaceuticals Sales Forecast by Type (2016-2021)
10.3 USA Biopharmaceuticals Sales Forecast by Application (2016-2021)
10.4 Biopharmaceuticals Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Biopharmaceuticals
Table Classification of Biopharmaceuticals
Figure USA Sales Market Share of Biopharmaceuticals by Type in 2015
Table Application of Biopharmaceuticals
Figure USA Sales Market Share of Biopharmaceuticals by Application in 2015
Figure USA Biopharmaceuticals Sales and Growth Rate (2011-2021)
Figure USA Biopharmaceuticals Revenue and Growth Rate (2011-2021)
Table USA Biopharmaceuticals Sales of Key Manufacturers (2015 and 2016)
Table USA Biopharmaceuticals Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biopharmaceuticals Sales Share by Manufacturers
Figure 2016 Biopharmaceuticals Sales Share by Manufacturers
Table USA Biopharmaceuticals Revenue by Manufacturers (2015 and 2016)
Table USA Biopharmaceuticals Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Biopharmaceuticals Revenue Share by Manufacturers
Table 2016 USA Biopharmaceuticals Revenue Share by Manufacturers
Table USA Market Biopharmaceuticals Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Biopharmaceuticals Average Price of Key Manufacturers in 2015
Figure Biopharmaceuticals Market Share of Top 3 Manufacturers
Figure Biopharmaceuticals Market Share of Top 5 Manufacturers
Table USA Biopharmaceuticals Sales by Type (2011-2016)
Table USA Biopharmaceuticals Sales Share by Type (2011-2016)
Figure USA Biopharmaceuticals Sales Market Share by Type in 2015
Table USA Biopharmaceuticals Revenue and Market Share by Type (2011-2016)
Table USA Biopharmaceuticals Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Biopharmaceuticals by Type (2011-2016)
Table USA Biopharmaceuticals Price by Type (2011-2016)
Figure USA Biopharmaceuticals Sales Growth Rate by Type (2011-2016)
Table USA Biopharmaceuticals Sales by Application (2011-2016)
Table USA Biopharmaceuticals Sales Market Share by Application (2011-2016)
Figure USA Biopharmaceuticals Sales Market Share by Application in 2015
Table USA Biopharmaceuticals Sales Growth Rate by Application (2011-2016)
Figure USA Biopharmaceuticals Sales Growth Rate by Application (2011-2016)
Table Abbott Laboratories Basic Information List
Table Abbott Laboratories Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Laboratories Biopharmaceuticals Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Biopharmaceuticals Sales Market Share (2011-2016)
Table Astrazeneca Basic Information List
Table Astrazeneca Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astrazeneca Biopharmaceuticals Sales Market Share (2011-2016)
Table BASF Basic Information List
Table BASF Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table BASF Biopharmaceuticals Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Biopharmaceuticals Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Biopharmaceuticals Sales Market Share (2011-2016)
Table Biogen Idec Basic Information List
Table Biogen Idec Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biogen Idec Biopharmaceuticals Sales Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim Biopharmaceuticals Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Biopharmaceuticals Sales Market Share (2011-2016)
Table Daiichi Sankyo Basic Information List
Table Daiichi Sankyo Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Daiichi Sankyo Biopharmaceuticals Sales Market Share (2011-2016)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company Biopharmaceuticals Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Biopharmaceuticals Sales Market Share (2011-2016)
Table Glaxosmithkline Basic Information List
Table Glaxosmithkline Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Glaxosmithkline Biopharmaceuticals Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Biopharmaceuticals Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Biopharmaceuticals Sales Market Share (2011-2016)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table LG Life Sciences Biopharmaceuticals Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Biopharmaceuticals Sales Market Share (2011-2016)
Table Novo Nordisk Basic Information List
Table Novo Nordisk Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novo Nordisk Biopharmaceuticals Sales Market Share (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Biopharmaceuticals Sales Market Share (2011-2016)
Table Ranbaxy Laboratories Basic Information List
Table Ranbaxy Laboratories Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ranbaxy Laboratories Biopharmaceuticals Sales Market Share (2011-2016)
Table Roche Holding Basic Information List
Table Roche Holding Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Holding Biopharmaceuticals Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Biopharmaceuticals Sales Market Share (2011-2016)
Table Takeda Pharmaceutical Company Basic Information List
Table Takeda Pharmaceutical Company Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Takeda Pharmaceutical Company Biopharmaceuticals Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Basic Information List
Table Teva Pharmaceutical Industries Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Biopharmaceuticals Sales Market Share (2011-2016)
Table UCB Basic Information List
Table UCB Biopharmaceuticals Sales, Revenue, Price and Gross Margin (2011-2016)
Table UCB Biopharmaceuticals Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biopharmaceuticals
Figure Manufacturing Process Analysis of Biopharmaceuticals
Figure Biopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2015
Table Major Buyers of Biopharmaceuticals
Table Distributors/Traders List
Figure USA Biopharmaceuticals Production and Growth Rate Forecast (2016-2021)
Figure USA Biopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Table USA Biopharmaceuticals Production Forecast by Type (2016-2021)
Table USA Biopharmaceuticals Consumption Forecast by Application (2016-2021)
  • C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 72
    C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) - Pipeline Review, H2 2017 Summary C-C Chemokine Receptor Type 5 (CHEMR13 or HIV 1 Fusion Coreceptor or CD195 or CCR5) pipeline Target constitutes close to 15 molecules. Out of which approximately 12 molecules are developed by companies and remaining by the universities/institutes. The latest report C-C Chemokine Receptor Type 5 - Pipeline Review, H2 2017, outlays comprehensive info......
  • C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 59
    C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - Pipeline Review, H2 2017 Summary C-X-C Chemokine Receptor Type 2 (CDw128b or GRO/MGSA Receptor or High Affinity Interleukin 8 Receptor B or IL8 Receptor Type 2 or CD182 or CXCR2) - CXCR2 or Interleukin 8 receptor, beta is a chemokine receptor. It binds to IL8 with high affinity, and transduces the signal through a G-prot......
  • C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 54
    C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017 Summary C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) pipeline Target constitutes close to 7 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) - Pipeline Review, H2 2017, outlays comprehensive information on the C5a Anaphylato......
  • Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 53
    Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Pipeline Review, H2 2017 Summary Prostaglandin D2 Receptor 2 (Chemoattractant Receptor Homologous Molecule Expressed On Th2 Cells or G Protein Coupled Receptor 44 or GPR44 or CD294 or PTGDR2) - Prostaglandin D2 (PGD2) receptors are G protein-coupled receptors that binds and is activated by prostaglandin D2. ......
  • Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 45
    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2017 Summary According to the recently published report 'Prostaglandin E2 Receptor EP4 Subtype - Pipeline Review, H2 2017'; Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) pipeline Target constitutes close to 11 molecules. Out of which approximately 10 molecules are developed by companies and remaining by the universities/institutes. ......
  • Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 74
    Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) - Pipeline Review, H2 2017 Summary Sphingosine 1-Phosphate Receptor 1 (Endothelial Differentiation G Protein Coupled Receptor 1 or Sphingosine 1 Phosphate Receptor Edg 1 or CD363 or S1PR1) pipeline Target constitutes close to 17 molecules. Out of which approximately 17 molecules are developed by Companies. The lat......
  • Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 49
    Glucagon Like Peptide 2 Receptor (GLP2R) - Pipeline Review, H2 2017 Summary Glucagon Like Peptide 2 Receptor (GLP2R) - Glucagon-like peptide 2 receptor (GLP-2R) is a protein encoded by the GLP2R gene. GLP2R, a G protein-coupled receptor superfamily member is expressed in the gut. GLP2 stimulates intestinal growth and up regulates villus height in the small intestine, concomitant with increased crypt cell proliferation and decreased enterocyte apoptosis. GLP2 prevent......
  • Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 3500 Onwards        Pages: 55
    Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017 Summary According to the recently published report 'Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) - Pipeline Review, H2 2017'; Metabotropic Glutamate Receptor 2 (GPRC1B or MGLUR2 or GRM2) pipeline Target constitutes close to 14 molecules. Out of which approximately 13 molecules are developed by companies and remaining by the universities/institutes. M......
  • Restenosis - Pipeline Review, H2 2017
    Published: 16-Aug-2017        Price: US 2000 Onwards        Pages: 48
    Restenosis - Pipeline Review, H2 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2017, provides an overview of the Restenosis (Cardiovascular) pipeline landscape. Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family hist......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs